article thumbnail

Bone Void Filler Cerament G: The Combination Product by BONESUPPORT Gets Market Authorization from the FDA

XTalks

Ceramanet G, a bone void filler with the antibiotic gentamicin, fills bone voids and immediately begins bone healing with protection. Cerament G is a bone void filler treatment that can fill the gaps in the affected bones and simultaneously deliver the antibiotic gentamicin to reduce the risk of reinfection. mg/mL of cerament paste.

Filler 96
article thumbnail

North America Aesthetic Filler Market 2019-2020 & Forecast to 2028 – ResearchAndMarkets.com

BioTech 365

North America Aesthetic Filler Market 2019-2020 & Forecast to 2028 – ResearchAndMarkets.com North America Aesthetic Filler Market 2019-2020 & Forecast to 2028 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “North America Aesthetic Filler Market 2019-2028” report has been added to ResearchAndMarkets.com’s (..)

Filler 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures

BioTech 365

Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures LEWISVILLE, Texas–(BUSINESS … Continue reading →

Filler 52
article thumbnail

Divisional Patent Minefields: Navigating Big Pharma’s Patent Extension Strategies

Drug Patent Watch

The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” by Mieke Filler provides a comprehensive analysis of the strategic use of divisional patents in the pharmaceutical sector to delay generic and biosimilar market entry.

Filler 98
article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

BONESUPPORT received market authorization from the FDA for Cerament G, the first and only bone graft with antibiotic elution that is approved for the US market. BONESUPPORT has recently received market authorization from the US Food and Drug Administration (FDA) for Cerament G, its bone graft with antibiotic elution.

Filler 98
article thumbnail

Bougie Bakes Enters the Pet Treat Market with Their New Bougie Barks

XTalks

The Bougie Bark cookies are preservative-free and do not contain any fillers. Therefore, it’s only natural for companies to cater to this growing consumer market. There is exponential growth in the pet treat market and it is predicted to reach $72.6 In 2020, the pet treats global market made an estimated $21.4

Marketing 105
article thumbnail

Medical Aesthetics: “Redefining Beauty through Medical Expertise”

Roots Analysis

Afterwards, in 2003, the FDA approved Hyaluronic Acid Fillers (HA dermal fillers), bringing the much-anticipated innovation to all types of face and non-face augmentation products. Moreover, at present, women dominate the medical aesthetics industry with over 90% market share.

Filler 40